Category Archives: LABD-25-08

‘Curve Fitting’ Biotech … Part 2

April 18, 2025 By in $SPSIBI, Biotech, LABD, LABD-25-08, Positions, SPBIO, XBI

Back To The Daily

Yesterday, the 3-Day chart was the best fit for biotech, XBI.

After Thursday’s action was complete, now the daily looks better.

Either way, we’ve got a tight stop (nearly hit, yesterday), and a trendline; decisive violation of either one, indicates an exit of (short biotech) LABD-25-08 (not advice, not a recommendation).

Biotech XBI, Daily

There’s so much going on with this chart.

We’re at the point where the downtrend either continues, or morphs into a different scenario.

Even as this post was created (late Thursday), the after-hours session continues slightly lower for XBI; an encouraging sign, if short (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

‘Curve Fitting’ Biotech … Part 1

April 17, 2025 By in $SPSIBI, Biotech, LABD, LABD-25-08, Positions, SPBIO, Speck-Effect, The Speck, ZeroHedge

Fibonacci, First

We’re letting the market decide what support/resistance, trendlines, and Fibonacci levels are significant.

We’ll even make an attempt to pick the timeframe(s) that best describes current action.

There’s a lot going on in a market sense, as well as ‘behind the scenes’ with revelations like this, and this, and this.

With that said, we’re looking at the 3-Day chart and Fibonacci levels.

Biotech XBI, 3-Day

The 3-Day is being used; it best shows current trending action (planned for next update).

The XBI, has near perfect (Fibonacci) symmetry.

Price action has made its way back to the 23.6%, level, and is hesitating.

Watching the action in real time, XBI gives the sense it does not know quite what to do … is it in a pause, gathering steam to move higher, or was the massive squeeze, on Wednesday, the 9th, all there was?

Positioning

As stated in the earlier update, XBI action on the 15th, put it at The Danger Point®; the location where risk was least for a short position (not advice, not a recommendation).

It’s been slow going since then (ratcheting lower) but the one thing XBI, is not doing … is moving significantly higher.

More trade discussion, stop levels, link here (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

After The Squeeze

April 16, 2025 By in $SPSIBI, Biotech, LABD, LABD-25-08, Positions, SPBIO, XBI 1 Comment

Biotech’s, Tale of Two Channels

What happens after the squeeze?

If it really was a squeeze, then demand evaporates, and prices (tend to) collapse (not advice, not a recommendation).

In the case of biotech, not only did we have a potential squeeze, two separate trading channels appear to be in effect.

Biotech, SPBIO, Daily

Both channels have contact points, Fibonacci 5 Days apart.

The more aggressive channel (grey dashed lines) has yet to be fully confirmed.

At this point, it’s essentially one contact on the right side.

Positioning

Remaining short this sector with LABD-25-08.

The stop has been moved (up on LABD) down to the XBI high, at XBI 76.24; effectively 10.24 on LABD, (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech … The Next Leg (Down)

April 15, 2025 By in $SPSIBI, Biotech, LABD, LABD-25-08, Positions, SPBIO, XBI, ZeroHedge 1 Comment

A-B-C, Correction

The market hits just keep coming for biotech.

First, it was this (RFK Jr., nominated, then confirmed), then it was this, and now, the latest is this.

While the financial press toys with the idea ‘the worst is over‘, (which might be true), with biotech, price action itself says it may be preparing for its next leg … lower.

Biotech XBI, Hourly

We’re drilling down to the hourly; it shows (as of 12:24 p.m., EST) a Fibonacci a-b-c, corrective retrace.

Wave ‘a’, was the massive short squeeze.

Wave ‘b’ was a test of the lows; then on to wave ‘c’, the same (net) distance as wave ‘a’, making it a 1:1 (potentially complete) corrective move.

Also note the ‘alternation’.

Wave ‘a’, was essentially straight up. Then, wave ‘c’ alternates and is a labored slow process, ratcheting higher.

We’re at The Danger Point®, where the risk of a short position is least (not advice, not a recommendation).

Currently short, Trade: LABD-25-08, with stop at the LABD, session low (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279